ArticleClinical drug investigation2022

Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US.

Buthainah Ghanem et al.PubMed ↗Publisher ↗

No numbers read from the abstract.